Ductal carcinoma in situ: what the pathologist needs to know and why. (Q36634452)

15 August 2017

Ductal carcinoma in situ: what the pathologist needs to know and why. (English)

1 reference

15 August 2017

1 reference

Anita Bane

1 reference

15 August 2017

6 February 2013

1 reference

International Journal of Breast Cancer

15 August 2017

1 reference

15 August 2017

2013

1 reference

15 August 2017

914053

1 reference

PMC publication ID

3580892

Creative Commons Attribution 3.0 Unported

15 August 2017

start time

1 January 2013

1 reference

April 2022 Public Data File from Crossref

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Choosing Treatment for Patients With Ductal Carcinoma In Situ: Fine Tuning the University of Southern California/Van Nuys Prognostic Index

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Breast cancer precursors revisited: molecular features and progression pathways

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Obesity, mammography use and accuracy, and advanced breast cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

An update on apocrine lesions of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Classification of ductal carcinoma in situ by gene expression profiling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Molecular evolution of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

The spectrum of apocrine lesions of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Ductal carcinoma in situ with microinvasion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Repeated observation of breast tumor subtypes in independent gene expression data sets

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Detection of ductal carcinoma in situ in women undergoing screening mammography

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Molecular portraits of human breast tumours

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Ductal carcinoma in situ: a proposal for a new classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Intraductal carcinoma of the breast: Follow-up after biopsy only

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Identification of a basal-like subtype of breast ductal carcinoma in situ

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Ductal carcinoma in situ of the breast: Reproducibility of histological subtype analysis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

A prognostic index for ductal carcinoma in situ of the breast

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580892

Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States).

28 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F914053

Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group

21 January 2018

1 reference

12 December 2020

Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast

1 reference

12 December 2020

On the origin and progression of ductal carcinoma in the human breast

1 reference

12 December 2020

Cystic hypersecretory duct carcinoma of the breast

1 reference

12 December 2020

Risk factors for breast cancer in women with proliferative breast disease

1 reference

12 December 2020

Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients

1 reference

12 December 2020

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

12 December 2020

Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee

1 reference

12 December 2020

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001

1 reference

12 December 2020

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

12 December 2020

Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast

1 reference

12 December 2020

Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy

1 reference

12 December 2020

Breast Cancer: Noninvasive and Special Situations

1 reference

12 December 2020

Encapsulated Papillary Carcinoma of the Breast

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/914053

1 reference

15 August 2017

1 reference

PMC publication ID

3580892

15 August 2017

PubMed publication ID

23476791

1 reference

PMC publication ID

3580892